Volume 11, Number 10—October 2005
Research
Pyrosequencing Bacillus anthracis
Table 2
Target | Primer | Sequence |
---|---|---|
rpoB | PCR forward | 5´-CCACCAACAGTAGAAAATGCCA-3´ |
PCR reverse | b-5´-AAATTTCACCAGTTTCTGGATCTA-3´ | |
Sequencing 911 | 5´-CACCAACAGTAGAAAATGC-3´ | |
Sequencing 912 | 5´-TTCTTCGATCCAAAGC-3´ | |
Sequencing 913 | 5´-TAAAAACAGATTGTTTA-3´ | |
Sequencing 914 | 5´-AACGTTTAGCTGAAACATT-3´ | |
pXO1 | PCR forward | 5´-GATATGAACCCGTACTTGTAAT-3´ |
PCR reverse | b-5´-GAATCAGATGCATTTTTAATGG-3´ | |
Sequencing | 5´-TTTATTATGAAATAGGT-3´ | |
pXO2 | PCR forward | 5´-TTCGCCTTGTGATTCCGCACT-3´ |
PCR reverse | b-5´-GGGCGCTGGTCGTATGTTTAG-3´ | |
Sequencing | 5´- TGTTTGTCCACTTCC-3´ |
*PCR, polymerase chain reaction; b, biotin.
Page created: February 21, 2012
Page updated: February 21, 2012
Page reviewed: February 21, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.